Data as of Mar 06
| +0.38 / +0.56%|
The 14 analysts offering 12-month price forecasts for DaVita HealthCare Partners Inc have a median target of 73.50, with a high estimate of 77.00 and a low estimate of 56.00. The median estimate represents a +6.91% increase from the last price of 68.75.
The current consensus among 17 polled investment analysts is to Buy stock in DaVita HealthCare Partners Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.